EX-21.1 4 fs12013a3ex21i_soligenix.htm CONSENT OF EISNER AMPER LLP Unassociated Document
EXHIBIT 21.1
 
SUBSIDIARIES OF SOLIGENIX, INC.

The following represents a list of Soligenix, Inc.’s subsidiaries:

Name
  
Ownership
    
  State of Incorporation
  
Enteron Pharmaceuticals, Inc.
    
100.00
%
  
Delaware
  
Orasomal Technologies Inc.
    
75.30
%
  
Delaware
  
BioDefense Corp.
    
100.00
%
  
Delaware
  
Soligenix BioPharma Canada Incorporated
    
100.00
%
  
Canada
  
Soligenix UK Limited
    
100.00
%
  
United Kingdom